Validation of an Adjusted Dosing Algorithm of Carboplatin

NCT02103244 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Carboplatin

Sponsor

Rijnstate Hospital